| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.077 | 0.04 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.04 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.077 | 0.04 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | -0.075 | 0.04 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.067 | 0.04 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.05 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.067 | 0.05 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.064 | 0.05 |